Evaluation and medical management of female urinary incontinence

Cleveland Clinic Journal of Medicine

Volumn 64, Issue 2, 1997, Pages 83-92

  Rackley, Raymond R ^a   Appell, Rodney A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETHANECHOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CONJUGATED ESTROGEN; DICYCLOVERINE; DOXAZOSIN; ESTRADIOL; ESTROGEN; HYOSCYAMINE; IMIPRAMINE; OXYBUTYNIN; PHENYLPROPANOLAMINE; PROPANTHELINE BROMIDE; PSEUDOEPHEDRINE; TERAZOSIN;

BEHAVIOR THERAPY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; REVIEW; URINE INCONTINENCE;

EID: 0031002264     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.64.2.83     Document Type: Review

References (7)

1. Urinary Incontinence Guideline Panel. Urinary incontinence in adults: acute and chronic management. Rockville, MD: US Dept of Health and Human Services, PHS, AHCPR; 1996. AHCPR publication no. 96-0682.
2. Herzog A, Fultz N. Urinary incontinence in the community: prevalence, consequence, management, and beliefs. Top Geriatr Rehabil 1988; 3:1-12.
3. Resnick N, Yalla S, Laurino E. The pathophysiology of urinary-incontinence among institutionalized elderly persons. N Engl J Med 1989; 320:1-7.
4. Hu T, Gabelko K, Weis K, et al. Clinical guideline and cost implications - the case of stress urinary incontinence. Geriatr Nephrol Urol 1994; 4:85-91.
5. Resnick N, Yalla S. Management of urinary incontinence in the elderly. N Engl J Med 1985; 313:800-804.
6. Thacker HL. Current issues in menopausal hormone replacement therapy. Cleve Clin J Med 1996; 63:344-353.
7. Ramsey S, Wagner T, Bavendam T. Estimated costs of treating stress urinary incontinence in elderly women according to the AHCPR Clinical Practice Guidelines. Am J Man Care, 1996; 2:147-154.